Sidechain structure–activity relationships of cyclobutane-based small molecule αvβ3 antagonists

Authors:

Abstract
Cyclobutanes provide a versatile scaffold for the synthesis of small molecule integrin antagonists with good metabolic stability and in vivo tolerability.
Funding Information
  • Prostate Cancer UK (Pilot Grant PA10-01)
  • Yorkshire Cancer Research (B002-PhD)

This publication has 43 references indexed in Scilit: